How much does teclistamab cost to buy and price reference

Teritusumab (Teclistamab) is a new bispecific antibody drug mainly used to treat patients with relapsed or refractory multiple myeloma. The drug simultaneously targets BCMA (B cell maturation antigen) and CD3 and activates T cells to kill tumor cells, showing significant clinical efficacy. As an innovative immunotherapy, teritusumab has been approved in many countries around the world and has gradually entered the Chinese market, providing a new treatment option for patients with multiple myeloma.

At present, teritusumab has been officially launched in China, but it has not yet been included in the national medical insurance directory. Therefore, patients need to bear higher drug costs when purchasing. The specific price varies by region, hospital and dosage. Patients generally need to purchase it through the pharmacy of a tertiary A hospital or oncology hospital. It is recommended to consult local medical institutions in advance to obtain the latest price information. Because this drug is a high-end biological agent, the cost of purchasing the drug is high, which has a certain impact on the financial burden of patients.

In the international market, the specifications of the original research version of teritusumab are153mg/1.7ml, and a box is priced at about more than 50,000 yuan, which is relatively expensive. Overseas patients are generally partially reimbursed through medical insurance or commercial insurance, but China currently lacks corresponding medical insurance policy support, so the price of imported drugs is still a big challenge for patients. In addition, some countries and regions are also actively promoting the development of generic versions of the drug in order to reduce treatment costs and improve patient accessibility.

Overall, as a new generation of immunotherapy drug, teritusumab has gradually become an important weapon in the treatment of multiple myeloma due to its unique mechanism of action and good efficacy. Although the price is higher, with the promotion of clinical application and the gradual improvement of medical insurance policies, its price is expected to be adjusted to a certain extent in the future, thereby benefiting more patients. When choosing a treatment plan, patients should fully consider drug efficacy and financial affordability, and formulate a reasonable treatment plan under the guidance of a doctor.

Reference materials:https://www.drugs.com/